Oruka Therapeutics develops antibody treatments for psoriasis and other immune and inflammatory conditions. It last closed at $95.81 on Nov 20, down 1.80% on the day. The next earnings report for ORKA is expected around Mon, Feb 8, 2027. Over its last 8 reports the stock moved an average of 3.6% the session after earnings. Over the last 12 months ORKA insiders bought $0 of stock on the open market and sold $344.6M, according to SEC Form 4 filings.
AI Auto Pilots
Is ORKA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ORKA.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ORKAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ORKA · as of the Nov 20 close · updated each morning
Uptrend
The stock sits between its 20 and 50 day averages. It is 23% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 50). The nearest support is the swing low (Aug 10) at $95.50, and the nearest resistance the swing high (Jul 20) at $96.27.
Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 5.9%/day
Key levels
$115.5252 week high+20.6%
$99.3620 day average+3.7%
$97.60Pivot R1+1.9%
$96.27Swing high (Jul 20)+0.5%
$95.81Last close
$95.50Swing low (Aug 10)−0.3%
$95.45Pivot−0.4%
$93.66Pivot S1−2.2%
$92.72100 day average−3.2%
$90.1250 day average−5.9%
$74.24200 day average−22.5%
$25.2352 week low−73.7%
Indicators
RSI (14)
50.05
Middle of its range
Neutral
MACD
2.73
Below its signal line
Bearish
Stochastic
13.3
Near the bottom of its range
Oversold
ADX (14)
28.2
Trending up
Williams %R
-87.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-65.1
Oversold below −100, overbought above 100
Neutral
Rate of change
−6.8%
Change over 10 sessions
Bearish
ATR (14)
$5.67
Typical daily range, 5.9% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityNormal, 11.6%/day
Key levels
$115.5252 week high+20.6%
$99.3620 day average+3.7%
$97.60Pivot R1+1.9%
$96.27Swing high (Jul 20)+0.5%
$95.81Last close
$95.50Swing low (Aug 10)−0.3%
$95.45Pivot−0.4%
$93.66Pivot S1−2.2%
$92.72100 day average−3.2%
$90.1250 day average−5.9%
$74.24200 day average−22.5%
$25.2352 week low−73.7%
Indicators
RSI (14)
57.40
Middle of its range
Neutral
MACD
7.47
Below its signal line
Bearish
Stochastic
68.5
Middle of its range
Neutral
ADX (14)
36.8
Trending up
Williams %R
-43.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
61.0
Oversold below −100, overbought above 100
Neutral
Rate of change
+3.7%
Change over 10 sessions
Bullish
ATR (14)
$11.08
Typical daily range, 11.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for ORKA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ORKA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ORKA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ORKAHow many large options trades hit ORKA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ORKA in the last 90 days.
From SEC Form 4 filings by ORKA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ORKA is in one of them and how their past ORKA trades turned out.
Oruka Therapeutics is a biopharmaceutical company based in Menlo Park, California. It is developing antibody treatments for psoriasis, a chronic skin disease, along with other immune and inflammatory conditions such as hidradenitis suppurativa and psoriatic arthritis. Its lead candidates are designed to act on IL-23 and IL-17 signaling. The company's products are still in clinical trials and not yet approved, and it aims to serve people living with these chronic skin and joint conditions.